The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levels

被引：16
|
作者：
Meiser, BM
Pfeiffer, M
Schmidt, D
Ueberfuhr, P
Reichenspurner, H
Paulus, D
von Scheidt, W
Kreuzer, E
Seidel, D
Reichart, B
机构：
[1] Univ Munich, Grosshadern Med Ctr, Dept Cardiac Surg, D-81366 Munich, Germany
[2] Univ Munich, Grosshadern Med Ctr, Inst Clin Chem, D-81366 Munich, Germany
[3] Univ Munich, Grosshadern Med Ctr, Dept Internal Med, D-81366 Munich, Germany
来源：
TRANSPLANTATION PROCEEDINGS | 1999年 / 31卷 / 1-2期
关键词：
D O I：
10.1016/S0041-1345(98)01448-1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：84 / 87
页数：4
相关论文
共 50 条
  • [1] The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid
    Kuriata-Kordek, M
    Boratynska, M
    Klinger, M
    Wozniak, M
    Urbaniak, J
    Szyber, P
    Patrzalek, D
    Tupka, D
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) : 2985 - 2987
  • [2] Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis
    Daudén, E
    Sánchez-Peinado, C
    Ruiz-Genao, D
    García-F-Villalta, M
    Onate, MJ
    García-Díez, A
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (01) : 132 - 135
  • [3] Combination of Everolimus and Tacrolimus in Kidney Transplant Patients With Intolerance to Mycophenolate Mofetil/Mycophenolic Acid
    Balda, S.
    Inza, A.
    Odriozola, N.
    Zarraga, S.
    Garcia-Erauskin, G.
    Lampreabe, I.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) : 2095 - 2098
  • [4] Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: Importance of mycophenolic acid therapeutic drug monitoring
    Meiser, BM
    Pfeiffer, M
    Schmidt, D
    Reichenspurner, H
    Ueberfuhr, P
    Paulus, D
    von Scheidt, W
    Kreuzer, E
    Seidel, D
    Reichart, B
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (02): : 143 - 149
  • [5] Tacrolimus/Mycophenolate Mofetil vs Cyclosporine/Mycophenolate Mofetil after HTx: Comparison of Mycophenolate Acid trough levels and coronary vasomotor function
    Meiser, B
    Groetzner, J
    Schirmer, J
    Van Scheidt, W
    Weis, M
    Koglin, J
    Klauss, V
    Stempfle, W
    Cremer, P
    Reichenspurner, H
    Reichert, B
    CIRCULATION, 2001, 104 (17) : 364 - 364
  • [6] Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels
    van Besouw, NM
    van der Mast, BJ
    Gregoor, PJHS
    Hesse, CJ
    IJzermans, JNM
    van Gelder, T
    Weimar, W
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (11) : 2710 - 2713
  • [7] 12 hour trough mycophenolic acid levels predict rejection, bone marrow suppression, viral infections and diarrhoea in renal transplant recipients immunosuppressed with mycophenolate mofetil and tacrolimus.
    Borrows, R
    Chusney, G
    van Tromp, J
    James, A
    Stichbury, J
    Cairns, T
    Griffith, M
    Hakim, N
    McLean, A
    Palmer, A
    Papalois, V
    Taube, D
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 254 - 254
  • [8] Relationship between mycophenolate mofetil side effects and mycophenolic acid plasma trough levels in renal transplant patients
    Hübner, GI
    Eismann, R
    Sziegoleit, W
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2000, 50 (10): : 936 - 940
  • [9] Mycophenolic acid reaches therapeutic levels whereas mycophenolate mofetil does not
    Vilalta Casas, R.
    Vila Lopez, A.
    Nieto Rey, J. L.
    Lara Moctezuma, L. E.
    Madrid Aris, A.
    Quintana Montero, M.
    Pou Clave, L.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) : 2400 - 2401
  • [10] Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation
    Zucker, K
    Tsaroucha, A
    Olson, L
    Esquenazi, V
    Tzakis, A
    Miller, J
    THERAPEUTIC DRUG MONITORING, 1999, 21 (01) : 35 - 43
12345